Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J F Robertson

Showing results (111-120 of 200) with videos related to

Pageof 20
Sort By:
Cancer Immunology, Immunotherapy : CII|January 1, 1990
Detection of polymorphic epithelial mucins in the serum of systemic breast cancer patients using the monoclonal antibody, NCRC-11M R Price, A J Clarke, J F Robertson, et al.
European Journal of Cancer & Clinical Oncology|March 1, 1989
Factors predicting the response of patients with advanced breast cancer to endocrine (Megace) therapyJ F Robertson, M R Williams, J Todd, et al.
British Journal of Cancer|November 1, 1990
Goserelin (Zoladex) in premenopausal advanced breast cancer: duration of response and survivalA R Dixon, J F Robertson, L Jackson, et al.
Breast Cancer Research and Treatment|January 1, 1994
Biological factors of prognostic significance in locally advanced breast cancerJ F Robertson, I O Ellis, D Pearson, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1991
Prospective assessment of the role of five tumour markers in breast cancerJ F Robertson, D Pearson, M R Price, et al.
European Journal of Cancer (Oxford, England : 1990)|October 26, 1999
The prognosis of small primary breast cancersJ Kollias, C A Murphy, C W Elston, et al.
The British Journal of Surgery|June 1, 1988
Effect of LHRH agonist, Zoladex, on ovarian histologyK Williamson, J F Robertson, I O Ellis, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 1, 1992
Silver-stained nucleolar organiser region counts are of no prognostic value in primary breast cancerN P Sacks, J F Robertson, I O Ellis, et al.
The Australian and New Zealand Journal of Surgery|September 1, 1996
Diagnosis of breast cancer with core-biopsy and fine needle aspiration cytologyG H Poole, P C Willsher, S E Pinder, et al.
The Journal of Pathology|October 1, 1989
An observation of DNA ploidy, histological grade, and immunoreactivity for tumour-related antigens in primary and metastatic breast carcinomaA Hitchcock, I O Ellis, J F Robertson, et al.
Pageof 20

Showing results (111-120 of 200) with videos related to

Sort By:
Pageof 20
Cancer Immunology, Immunotherapy : CII|January 1, 1990
Detection of polymorphic epithelial mucins in the serum of systemic breast cancer patients using the monoclonal antibody, NCRC-11M R Price, A J Clarke, J F Robertson, et al.
European Journal of Cancer & Clinical Oncology|March 1, 1989
Factors predicting the response of patients with advanced breast cancer to endocrine (Megace) therapyJ F Robertson, M R Williams, J Todd, et al.
British Journal of Cancer|November 1, 1990
Goserelin (Zoladex) in premenopausal advanced breast cancer: duration of response and survivalA R Dixon, J F Robertson, L Jackson, et al.
Breast Cancer Research and Treatment|January 1, 1994
Biological factors of prognostic significance in locally advanced breast cancerJ F Robertson, I O Ellis, D Pearson, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1991
Prospective assessment of the role of five tumour markers in breast cancerJ F Robertson, D Pearson, M R Price, et al.
European Journal of Cancer (Oxford, England : 1990)|October 26, 1999
The prognosis of small primary breast cancersJ Kollias, C A Murphy, C W Elston, et al.
The British Journal of Surgery|June 1, 1988
Effect of LHRH agonist, Zoladex, on ovarian histologyK Williamson, J F Robertson, I O Ellis, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 1, 1992
Silver-stained nucleolar organiser region counts are of no prognostic value in primary breast cancerN P Sacks, J F Robertson, I O Ellis, et al.
The Australian and New Zealand Journal of Surgery|September 1, 1996
Diagnosis of breast cancer with core-biopsy and fine needle aspiration cytologyG H Poole, P C Willsher, S E Pinder, et al.
The Journal of Pathology|October 1, 1989
An observation of DNA ploidy, histological grade, and immunoreactivity for tumour-related antigens in primary and metastatic breast carcinomaA Hitchcock, I O Ellis, J F Robertson, et al.
Pageof 20